Licarbazepine Top: (R )-(−)-licarbazepine Bottom: (S )-(+)-licarbazepine
ATC code Protein binding <40% Metabolites Glucuronides Excretion Mainly renal
(RS )-10,11-Dihydro-10-hydroxy-5H -dibenz[b,f]azepine-5-carboxamide
CAS Number PubChem CID ChemSpider UNII KEGG ChEMBL CompTox Dashboard (EPA ) ECHA InfoCard 100.122.427 Formula C 15 H 14 N 2 O 2 Molar mass 254.289 g·mol−1 3D model (JSmol ) Chirality Racemic mixture
NC(=O)N1c2ccccc2CC(O)c3ccccc13
InChI=1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)
Key:BMPDWHIDQYTSHX-UHFFFAOYSA-N
Licarbazepine is a voltage-gated sodium channel blocker with anticonvulsant and mood-stabilizing effects that is related to oxcarbazepine .[1] It is an active metabolite of oxcarbazepine .[1] [2] In addition, an enantiomer of licarbazepine, eslicarbazepine ((S )-(+)-licarbazepine), is an active metabolite of eslicarbazepine acetate .[1] [2] Oxcarbazepine and eslicarbazepine acetate are inactive on their own, and behave instead as prodrugs to licarbazepine and eslicarbazepine, respectively, to produce their therapeutic effects.[1] [2]
References [ ]
Anticonvulsants (N03 )
GABAergics
Channel modulators
Sodium blockers Calcium blockers
Oxazolidinediones : Ethadione
Paramethadione
Trimethadione ; Succinimides : Ethosuximide #
Mesuximide
Phensuximide ; Gabapentinoids : Gabapentin
Pregabalin ; Others: Imepitoin
Lamotrigine #
Topiramate
Zonisamide
Potassium openers
Others
CA inhibitors
Sulfonamides : Acetazolamide
Ethoxzolamide
Sultiame
Topiramate
Zonisamide
Others
Albutoin
Beclamide
Cannabidiol
Etiracetam
Levetiracetam
Perampanel
# WHO-EM
‡ Withdrawn from market
Clinical trials :
† Phase III
§ Never to phase III
Mood stabilizers
Anticonvulsants
Carbamazepine
Lamotrigine
Oxcarbazepine
Valproate
Valnoctamide
Valproate pivoxil
Valpromide
Atypical antipsychotics
Aripiprazole
Asenapine
Cariprazine
Clozapine
Lurasidone
Olanzapine (+fluoxetine )
Paliperidone
Quetiapine
Risperidone
Ziprasidone
Others
Ketamine
Lithium (lithium acetate , lithium carbonate , lithium chloride , lithium citrate , lithium hydroxide , lithium orotate )
Omega-3 fatty acids (docosahexaenoic acid , eicosapentaenoic acid )
Neuropathic pain and fibromyalgia pharmacotherapies
Monoaminergics
SNRIs (e.g., duloxetine , milnacipran )
TCAs (e.g., amitriptyline , nortriptyline , dosulepin )
Opioid MRIs (e.g., tapentadol , tramadol )
Ion channel blockers
Anticonvulsants (e.g., gabapentin , pregabalin , mirogabalin , carbamazepine , oxcarbazepine , lacosamide , lamotrigine )
Local anesthetics (e.g., lidocaine )
Mexiletine
TCAs (e.g., amitriptyline , nortriptyline , desipramine )
Ziconotide
Others
Alpha lipoic acid
Benfotiamine
Botulinum toxin A
Bupropion
Cannabinoids (e.g., cannabis , dronabinol , nabilone )
NMDA receptor antagonists (e.g., ketamine , dextromethorphan , methadone )
Opioids (e.g., hydrocodone , morphine , oxycodone , methadone , buprenorphine , tramadol , tapentadol )
Sodium oxybate (GHB )
Calcium
Potassium
Sodium
VGSCs
Blockers
Antiarrhythmics (class I): Ajmaline
Aprindine
Disopyramide
Dronedarone
Encainide
Flecainide
Lidocaine
Lorajmine
Lorcainide
Mexiletine
Moricizine
Pilsicainide
Prajmaline
Procainamide
Propafenone
Quinidine
Sparteine
Tocainide
Analgesics:
DSP-2230
Funapide
PF-05089771
Ralfinamide
Raxatrigine
Toxins: Conotoxins
Neosaxitoxin
Saxitoxin
Tetrodotoxin
Zetekitoxin AB
Others: Buprenorphine
Evenamide
Menthol (mint )
Safinamide
Tricyclic antidepressants
Activators
ENaC
Blockers
Amiloride
Benzamil
Triamterene
Activators
ASICs
Blockers
Amiloride
Aspirin
Ibuprofen
Chloride
Others
See also: Receptor/signaling modulators • Transient receptor potential channel modulators
Tricyclics
Classes Antidepressants (TCAs and TeCAs ) Antihistamines Antipsychotics Anticonvulsants Others